Keywords: eon, gets, ok, 2nd, generic, adderall, labs
Eon gets OK for 2nd generic of Adderall
Article | 24 June 2002
Eon Labs has received final approval for its generic version of ShirePharmaceutical's attention-deficit hyperactivity disorder treatment Adderall (mixed amphetamine salts) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
